Registry of Deep Brain Stimulation With the VERCISE™ System for Treatment of Dystonia: Vercise DBS Dystonia Registry

To compile characteristics of real-world outcomes of Boston Scientific Corporation's
commercially approved VerciseTM Deep Brain Stimulation (DBS) Systems for the treatment of
dystonia.

Subjects' improvement in disease symptoms and overall Quality of life will be assessed.

Inclusion Criteria (IC):

- IC1. Meets criteria established in the locally applicable Vercise System Directions
for Use (DFU) for dystonia.

- IC2. At least 7 years old. Parent or guardian consent is required in patients who are
younger than 18 years at the time of consent.

Exclusion Criteria (EC):

- EC1. Meets any contraindication in the Vercise System locally applicable Directions
for Use.